Clinical Trials Directory

Trials / Conditions / Ann Arbor Stage III Diffuse Large B-Cell Lymphoma

Ann Arbor Stage III Diffuse Large B-Cell Lymphoma

6 registered clinical trials studyying Ann Arbor Stage III Diffuse Large B-Cell Lymphoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
NCT04139304
AIDS Malignancy ConsortiumEARLY_Phase 1
SuspendedTesting CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diag
NCT04799275
National Cancer Institute (NCI)Phase 2 / Phase 3
Active Not RecruitingParsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Ly
NCT04323956
Mayo ClinicPhase 1
Active Not RecruitingIbrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochlor
NCT03220022
National Cancer Institute (NCI)Phase 1
Active Not RecruitingRituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed
NCT01856192
National Cancer Institute (NCI)Phase 2
CompletedVorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-C
NCT01193842
National Cancer Institute (NCI)Phase 1 / Phase 2